MacroGenics, Inc. is a clinical-stage biopharmaceutical company based in Rockville, Maryland, focused on developing cutting-edge antibody-based therapies for cancer treatment. Utilizing proprietary technology platforms, MacroGenics seeks to address critical unmet medical needs in oncology through a robust pipeline of differentiated drug candidates. By establishing strategic partnerships and advancing its clinical programs, the company is poised to enhance treatment options and patient outcomes in oncology, positioning itself for substantial growth in the dynamic cancer therapeutics market.
Click "Analyze" to generate stock analysis
MGNX Price Trend and Signals
MGNX Option Volumes & Open Interests (aggregated)
MGNX Put Call Ratios and IV (aggregated)
MGNX Financials
2025-10-21Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.